Therefore, we concluded that IQGAP1/3 are oncogenes in HCC, where they promote advancement and metastasis and shorten the survival time of patients, while IQGAP2 is a tumor suppressor in HCC since its decrease in expression coincides with the clinicopathological characteristics and prognosis of patients. Here, IQGAP2 is linked to hepatocellular carcinoma.